David J Moss - 14 May 2024 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Financial Officer, 10%+ Owner
Signature
/s/ David Moss
Issuer symbol
INMB
Transactions as of
14 May 2024
Net transactions value
$0
Form type
4
Filing time
16 May 2024, 16:09:34 UTC
Previous filing
23 Apr 2024
Next filing
16 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +160,000 $0.000000 160,000 14 May 2024 Common Stock 160,000 $9.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the 2021 Stock Incentive Plan. One fourth (1/4) of the option will vest 12 months from the grant date and thereafter the remaining unvested option will become vested and exercisable on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the grant date.